Research ArticleClinical Studies

Efficacy of Combination Therapy With Radium-223 and Enzalutamide in Castration-resistant Prostate Cancer With Bone Metastases

NAOTO WAKITA, TAKUTO HARA, KOTARO SUZUKI, TOMOAKI TERAKAWA, JUN TEISHIMA, YUZO NAKANO and HIDEAKI MIYAKE
Anticancer Research June 2024, 44 (6) 2627-2635; DOI: https://doi.org/10.21873/anticanres.17069

Article Information

vol. 44 no. 6 2627-2635
DOI 
https://doi.org/10.21873/anticanres.17069
PMID 
38821616
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received April 2, 2024
  • Revision received April 18, 2024
  • Accepted April 19, 2024
  • Published online May 31, 2024.
Copyright & Usage 
Copyright © 2024 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. NAOTO WAKITA⇑,
  2. TAKUTO HARA,
  3. KOTARO SUZUKI,
  4. TOMOAKI TERAKAWA,
  5. JUN TEISHIMA,
  6. YUZO NAKANO and
  7. HIDEAKI MIYAKE
  1. Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan
  1. Correspondence to: Naoto Wakita, MD, Department of Urology, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Kobe 650-0017, Japan. Tel: +81 783826155, Fax: +81 783826169, e-mail: complus_duefl{at}yahoo.co.jp
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Efficacy of Combination Therapy With Radium-223 and Enzalutamide in Castration-resistant Prostate Cancer With Bone Metastases
NAOTO WAKITA, TAKUTO HARA, KOTARO SUZUKI, TOMOAKI TERAKAWA, JUN TEISHIMA, YUZO NAKANO, HIDEAKI MIYAKE
Anticancer Research Jun 2024, 44 (6) 2627-2635; DOI: 10.21873/anticanres.17069
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords